• Silymarin Workflows for Reproducible Research

  2026-08-25

  Build better oxidative-stress, liver-cancer, metabolic, and antiviral experiments with a mixture-aware Silymarin workflow. This guide combines solvent control, dose-ranging, orthogonal readouts, and chemistry-informed troubleshooting for more interpretable bench data.

• QNZ (EVP4593) for Reliable NF-κB Assays

  2026-08-24

  A scenario-based guide to using QNZ (EVP4593), SKU A4217, in NF-κB, viability, proliferation, inflammation, and neurodegenerative disease experiments. It explains dose selection, solvent control, stock preparation, data interpretation, and practical criteria for evaluating supplier reliability.

• SAG: Practical Hedgehog Pathway Activation Workflows

  2026-08-23

  SAG is a Smoothened receptor agonist for reproducible Hedgehog pathway activation, with practical value in reporter assays, neural regeneration models, developmental studies, and pathway-on controls for tumorigenesis research. This guide connects concentration selection, orthogonal readouts, formulation, and troubleshooting to experimental decisions rather than treating SAG as a one-size-fits-all reagent.

• Olaparib for DNA Damage Response Assays

  2026-08-22

  Olaparib, also known as AZD2281, is a practical tool for connecting PARP inhibition with replication-fork stress, nascent-strand maturation, and BRCA-dependent repair. This workflow-oriented guide shows how to design reproducible DNA damage response assays, radiosensitization experiments, and troubleshooting controls around the compound.

• Aclacinomycin A: Reading DNA Damage in Context

  2026-08-21

  Aclacinomycin A, or Aclarubicin, is a dual topoisomerase inhibitor that connects topological stress with apoptosis and proteasome biology. This article explains how to use it as a mechanistic probe while avoiding overinterpretation of persistent ribosomal-DNA damage and PML-nucleolar responses.

• AMPK–SQSTM1 Feedback in Metabolic Stress

  2026-08-21

  The 2024 Autophagy study identifies a double-positive feedback loop in which AMPK and SQSTM1/p62 reinforce one another during metabolic stress. This circuit coordinates lysosomal signaling, KEAP1 degradation, NRF2 activation, and antioxidant adaptation, offering a mechanistic explanation for how cancer cells maintain growth under nutrient and oxidative pressure.

• BRCA2, RAD51 and PARP1 Retention in DNA Repair

  2026-08-20

  The 2025 Nature study identifies PARP inhibitor-mediated PARP1 retention on resected DNA as a direct threat to RAD51 filament stability and DNA strand exchange. Using biochemical reconstitution, smFRET, and quantitative single-molecule localization microscopy, the authors show that full-length BRCA2 protects homologous recombination repair sites by preventing PARP1 from binding DNA.

• Uremic Metabolite Adsorption on Hydroxy-PEO Films

  2026-08-20

  This 2025 study advances uremic-toxin research by measuring adsorption of a 25-metabolite mixture on hydroxy-terminated polyethylene oxide films rather than relying on single-analyte or protein-only models. Its results show that PEO chain density, incubation time, end-group chemistry, and metabolite structure jointly determine surface retention, providing a more realistic framework for blood-contacting biomaterial design.

• CART–RNA Nanoparticles: Structure and Morphology

  2026-08-19

  Hurst and colleagues define how degradable Charge-Altering Releasable Transporter amphiphiles organize RNA into coacervate nanoparticles with disordered bicontinuous internal domains. By combining cryo-electron microscopy, tomography, and small-angle scattering, the study links amphiphile molar mass, chemical structure, and RNA cargo identity to nanoscale morphology, offering experimentally testable principles for polymer-based RNA delivery design.

• AP2-M Controls Babesia Asexual Replication

  2026-08-19

  A 2024 study identifies AP2-M, an Apicomplexan AP2-family transcription factor, as a regulator of red blood cell invasion, merozoite morphology, and cell-cycle progression in Babesia sp. Xinjiang. By combining Cut&Tag, RNA sequencing, proteomics, and single-cell RNA sequencing, the authors connect promoter occupancy with parasite-stage-specific transcriptional and phenotypic changes.

• PDGF-BB Murine Recombinant Protein Guide

  2026-08-18

  PDGF-BB, including murine recombinant PDGF-BB, is a defined mitogenic growth factor for receptor signaling and cell proliferation assays. Product specifications support controlled use in BALB/c 3T3 assays, while recent pulmonary hypertension research places smooth muscle cell proliferation within a lactate–ALDOB–DRP1 mechanism.

• Glabridin–Gold(I) Complex and Antitumor Immunity

  2026-08-18

  The reference study develops complex 6d by integrating an N-heterocyclic carbene gold(I) center with glabridin to target thioredoxin reductase and MAPK signaling. In liver cancer models, this design reportedly increased dendritic-cell maturation, reduced immunosuppressive immune populations, lowered tumor-cell PD-L1, and enhanced T-cell granzyme B production, supporting further evaluation of redox-directed immunomodulation.

• Catalpol in Alzheimer’s Disease: Mechanisms and Evidence

  2026-08-17

  This review synthesizes preclinical evidence that catalpol, an iridoid glycoside from Rehmannia glutinosa, may protect against Alzheimer’s disease through antioxidant, anti-inflammatory, antiapoptotic, and broader neuroprotective actions. Its main practical contribution is a multitarget framework for designing experiments that connect cognitive outcomes with cellular, molecular, and tissue-level mechanisms.

• EZ Cap™ Firefly Luciferase mRNA for LNP QC

  2026-08-16

  EZ Cap™ Firefly Luciferase mRNA can function as more than a reporter: it provides a sensitive functional readout for mRNA delivery, translation, and formulation effects. This article connects Cap1-enabled expression with citrate-buffer decisions in LNP development and assay design.

• Ceramides Drive RGNNV Infection Through Autophagy

  2026-08-15

  A 2026 Journal of Virology study uses global lipidomics and functional perturbation to show that red-spotted grouper nervous necrosis virus redirects ceramide metabolism to support replication. Ceramide synthesis, particularly C16-ceramide, promoted infection partly by enhancing virus-associated autophagy, identifying sphingolipid flux as a potential antiviral research target.

453 records 7/31 page Previous Next First page 上5页 678910 下5页 Last page